PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Sold by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lessened its stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 3.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 685,709 shares of the biopharmaceutical company’s stock after selling 21,021 shares during the period. […]
Charles Schwab Investment Management Inc. lessened its stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 3.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 685,709 shares of the biopharmaceutical company’s stock after selling 21,021 shares during the period. […]
-public-limited-logo-1200x675.jpg?v=20230412074258&w=240&h=240&zc=2){kind=logo}
